Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Impact of coxsackievirus-B4E2 combined with a single low dose of streptozotocin on pancreas of outbred mice: investigation of viral load, pathology and inflammation.

Benkahla MA, Sane F, Bertin A, Vreulx AC, Elmastour F, Jaidane H, Desailloud R, Hober D.

Sci Rep. 2019 Jul 12;9(1):10080. doi: 10.1038/s41598-019-46227-3.

2.

Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing Cells.

Bertin A, Sane F, Gmyr V, Lobert D, Dechaumes A, Kerr-Conte J, Pattou F, Hober D.

Viruses. 2019 Jul 2;11(7). pii: E597. doi: 10.3390/v11070597.

3.

Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Nekoua MP, Bertin A, Sane F, Alidjinou EK, Lobert D, Trauet J, Hober C, Engelmann I, Moutairou K, Yessoufou A, Hober D.

Cell Mol Life Sci. 2019 Jun 6. doi: 10.1007/s00018-019-03168-4. [Epub ahead of print]

PMID:
31172216
4.

Evaluation of the reverse transcription strand invasion based amplification (RT-SIBA) RSV assay, a rapid molecular assay for the detection of respiratory syncytial virus.

Alidjinou EK, Lefebvre N, Dewilde A, Mäki M, Hober D, Engelmann I.

Diagn Microbiol Infect Dis. 2019 Sep;95(1):55-58. doi: 10.1016/j.diagmicrobio.2019.04.006. Epub 2019 Apr 26.

PMID:
31160164
5.

Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4.

Alidjinou EK, Bertin A, Sane F, Caloone D, Engelmann I, Hober D.

Viruses. 2019 May 28;11(6). pii: E486. doi: 10.3390/v11060486.

6.

Routine drug resistance testing in proviral HIV-1 DNA: Prevalence of stop codons and hypermutation, and associated factors.

Alidjinou EK, Deldalle J, Robineau O, Hallaert C, Meybeck A, Huleux T, Ajana F, Hober D, Bocket L.

J Med Virol. 2019 Sep;91(9):1684-1687. doi: 10.1002/jmv.25474. Epub 2019 Apr 13.

PMID:
30927451
7.

Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro.

Badia-Boungou F, Sane F, Alidjinou EK, Hennebelle T, Roumy V, Ngakegni-Limbili AC, Nguimbi E, Moukassa D, Abena AA, Hober D.

J Med Virol. 2019 Jul;91(7):1210-1216. doi: 10.1002/jmv.25436. Epub 2019 Mar 3.

PMID:
30788849
8.

Diabetes progression and alterations in gut bacterial translocation: prevention by diet supplementation with human milk in NOD mice.

Sane F, Scuotto A, Pierrat V, Kacet N, Hober D, Romond MB.

J Nutr Biochem. 2018 Dec;62:108-122. doi: 10.1016/j.jnutbio.2018.08.017. Epub 2018 Oct 4.

PMID:
30292969
9.

Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo.

Benkahla MA, Alidjinou EK, Sane F, Desailloud R, Hober D.

Antiviral Res. 2018 Nov;159:130-133. doi: 10.1016/j.antiviral.2018.10.002. Epub 2018 Oct 2.

PMID:
30290197
10.

Serum-derived IgG from coxsackievirus A6-infected patients can enhance the infection of peripheral blood mononuclear cells with coxsackievirus A6.

Aswathyraj S, Sane F, Raghu C, Sabeena S, Alidjinou EK, Arunkumar G, Hober D.

Microb Pathog. 2018 Dec;125:7-11. doi: 10.1016/j.micpath.2018.08.064. Epub 2018 Sep 4.

PMID:
30193952
11.

miRNAs in enterovirus infection.

Engelmann I, Alidjinou EK, Bertin A, Sane F, Hober D.

Crit Rev Microbiol. 2018 Nov;44(6):701-714. doi: 10.1080/1040841X.2018.1499608. Epub 2018 Aug 14. Review.

PMID:
30106324
12.

Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses.

Ferlin J, Farhat R, Belouzard S, Cocquerel L, Bertin A, Hober D, Dubuisson J, Rouillé Y.

J Gen Virol. 2018 Aug;99(8):1086-1096. doi: 10.1099/jgv.0.001099. Epub 2018 Jun 20.

PMID:
29923822
13.

Salivary anti-coxsackievirus-B4 neutralizing activity and pattern of immune parameters in patients with type 1 diabetes: a pilot study.

Nekoua MP, Yessoufou A, Alidjinou EK, Badia-Boungou F, Moutairou K, Sane F, Hober D.

Acta Diabetol. 2018 Aug;55(8):827-834. doi: 10.1007/s00592-018-1158-3. Epub 2018 May 17.

PMID:
29774468
14.

Relapsing Pityriasis Rosea With HHV-7 Reactivation in an 11-Year-Old Girl.

Engelmann I, Ogiez J, Ogiez L, Alidjinou EK, Lazrek M, Dewilde A, Hober D.

Pediatrics. 2018 May;141(5). pii: e20173179. doi: 10.1542/peds.2017-3179. Epub 2018 Apr 19.

15.

Inhibition of coxsackievirus B4 by Lactobacillus plantarum.

Arena MP, Elmastour F, Sane F, Drider D, Fiocco D, Spano G, Hober D.

Microbiol Res. 2018 May;210:59-64. doi: 10.1016/j.micres.2018.03.008. Epub 2018 Mar 19.

16.

Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV.

Engelmann I, Alidjinou EK, Lazrek M, Pouillaude JM, Ogiez J, Rose F, Duhamel A, Dewilde A, Hober D.

J Med Microbiol. 2018 Apr;67(4):529-536. doi: 10.1099/jmm.0.000702. Epub 2018 Feb 26.

PMID:
29480795
17.

Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMV.

Engelmann I, Alidjinou EK, Lazrek M, Ogiez J, Pouillaude JM, Chazard E, Dewilde A, Hober D.

Diagn Microbiol Infect Dis. 2018 May;91(1):27-33. doi: 10.1016/j.diagmicrobio.2017.12.021. Epub 2018 Jan 7.

PMID:
29463426
18.

Necrotizing Enterocolitis Cases Associated with Nosocomial Enterovirus Transmission in a Neonatal Unit.

Alidjinou EK, Lazrek M, Schuffenecker I, Pindi B, Lapeyre F, Kacet N, Dewilde A, Engelmann I, Hober D.

Pediatr Infect Dis J. 2018 Sep;37(9):954-957. doi: 10.1097/INF.0000000000001928.

PMID:
29389824
19.

Diabetes: Towards a coxsackievirus B-based vaccine to combat T1DM.

Hober D, Alidjinou EK.

Nat Rev Endocrinol. 2018 Mar;14(3):131-132. doi: 10.1038/nrendo.2017.184. Epub 2018 Jan 12. No abstract available.

PMID:
29327705
20.

Very slow decline of hepatitis B virus surface antigen and core related antigen in chronic hepatitis B patients successfully treated with nucleos(t)ide analogues.

Alidjinou EK, Michel C, Canva V, Ajana F, Hober D, Bocket L.

J Med Virol. 2018 May;90(5):989-993. doi: 10.1002/jmv.25028. Epub 2018 Jan 30.

PMID:
29315722

Supplemental Content

Loading ...
Support Center